Physician profile
Tarick Megahed
NPI 1144756214
$6,369.44
in general payments reported to CMS, 2019-2025
10 companies · $1,769 in 2025
The $1,769 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.76 · 2022: $1,232 · 2023: $1,553 · 2024: $1,717 · 2025: $1,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,953 · Travel and Lodging: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,953.13 |
| Travel and Lodging | $1,085.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,623.57 | 2021-2025 | Obsidio, General - Embolics, Embold Fibered |
| Penumbra, INC. | $1,055.22 | 2023-2025 | Indigo System, Penumbra System, Ruby Coil |
| Inari Medical, INC. | $785.23 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $625.01 | 2024 | Augment Injectable |
| Siemens Medical Solutions USA, INC. | $468.58 | 2022 | |
| Sirtex Medical INC | $364.36 | 2023-2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Medtronic, INC. | $203.12 | 2022-2024 | Emprint |
| Abiomed | $126.48 | 2025 | |
| Nevro Corp. | $104.48 | 2024 | Senza |
| Angiodynamics, INC. | $13.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarick Megahed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.